Related Experiment Videos
Wnt-5a gene expression in malignant human neuroblasts.
Etienne Blanc1, David Goldschneider, Sétha Douc-Rasy
1Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), Unité Mixte de Recherche 8126, IFR 54, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France.
Cancer Letters
|June 1, 2005
Summary
Wnt-5a gene expression is decreased in high-risk neuroblastoma (NB). Retinoic acid (RA) can reverse this, suggesting Wnt-5a
Area of Science:
- Pediatric Oncology
- Molecular Biology
- Developmental Neuroscience
Background:
- Neuroblastoma (NB) is a challenging pediatric cancer, particularly in disseminated forms.
- Wnt-5a, a Wnt signaling pathway member, influences embryonic development and cancer metastasis.
- Altered Wnt-5a expression is implicated in melanoma and breast cancer progression.
Purpose of the Study:
- To investigate the role of Wnt-5a in high-risk neuroblastoma (HR-NB) pathogenesis.
- To explore the effect of retinoic acid (RA) on Wnt-5a regulation in metastatic neuroblasts.
- To elucidate the Wnt/calcium signaling pathway's involvement in NB.
Main Methods:
- Quantitative analysis of Wnt-5a gene expression in HR-NB and metastatic neuroblast cultures.
- Assessment of RA's impact on Wnt-5a regulation.
- Evaluation of beta-catenin and PKC-theta expression levels.
Main Results:
- Wnt-5a gene expression is significantly decreased in HR-NB and metastatic neuroblasts.
- Retinoic acid (RA) treatment reverses the negative regulation of Wnt-5a in metastatic neuroblasts.
- PKC-theta expression increases, paralleling Wnt-5a levels, while beta-catenin remains unchanged.
Conclusions:
- Wnt-5a downregulation is a feature of high-risk neuroblastoma.
- The Wnt/calcium signaling pathway, modulated by RA and involving PKC-theta, plays a role in NB pathogenesis.
- Targeting Wnt-5a may offer new therapeutic strategies for pediatric neuroblastoma.